Proquad Global Market Report 2025

Name: Proquad Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Proquad Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Measles, Mumps, Rubella, Varicella), By Patient Type (Pediatric Patient, Adult Patient), By End User (Healthcare Providers, Pharmacies, Public Health Organization)

Proquad Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Proquad Market?

Proquad is a vaccine designed to protect against measles, Mumps, rubella (MMR), and Varicella (chickenpox). It is a combination vaccine, meaning it combines multiple vaccines into one shot to reduce the number of injections needed for immunization. It is used primarily in children, typically administered as a single dose for those between 12 months and 12 years of age.

The main types of indications for proquad include measles, mumps, rubella, and varicella. The measles segment focuses on vaccines specifically designed to prevent measles, a highly contagious viral disease, administered in childhood and is part of the MMR (measles, mumps, and rubella) combination vaccine. The patient types include pediatric patients and adult patients and used by various end users such as healthcare providers, pharmacies, and public health organizations.

Proquad Market Size and growth rate 2025 to 2029: Graph

What Is The Proquad Market Size 2025 And Growth Rate?

The proquad market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to established immunization schedules, combination vaccine advantages, government-supported vaccination programs, epidemic outbreaks, strong healthcare infrastructure, and regulatory approvals.

What Is The Proquad Market Growth Forecast?

The proquad market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to population growth, improved access to healthcare, global health initiatives, rising awareness of vaccine-preventable diseases, government vaccination funding, and a growing focus on preventive healthcare. Major trends in the forecast period include global vaccination coverage, technological advancements in vaccine delivery, integration of vaccines in routine health systems, improvements in vaccine accessibility, and increased awareness of vaccine safety.

Book your 30 minutes free consultation with our research experts

How Is The Proquad Market Segmented?

The proquad market covered in this report is segmented –

1) By Indication: Measles; Mumps; Rubella; Varicella

2) By Patient Type: Pediatric Patient; Adult Patient

3) By End User: Healthcare Providers; Pharmacies; Public Health Organization

What Is Driving The Proquad Market? Rising Measles And Chickenpox Cases Drive Growth In The Market

The rising incidence of measles and chickenpox is expected to propel the growth of the proquad market going forward. Measles is a highly contagious viral infection characterized by fever, cough, and a red rash, preventable through vaccination, while chickenpox is a contagious disease caused by the Varicella-zoster virus, marked by an itchy blister-like rash and preventable with a vaccine. Measles and chickenpox cases are rising due to declining vaccination rates, misinformation about vaccines, increased global travel, and outbreaks in unvaccinated populations, leading to the re-emergence of these preventable diseases. Proquad, a combination vaccine for measles, mumps, rubella, and varicella (chickenpox), helps protect against these diseases by providing immunity through a single dose, reducing the risk of infection, controlling outbreaks, and ensuring comprehensive coverage to prevent complications associated with measles and chickenpox. For instance, in May 2024, according to the World Health Organization, a Switzerland-based non-profit organization, 56,634 measles cases and four deaths were officially reported across 45 out of 53 countries in the WHO European Region during the first three months of 2024. Throughout 2023, 61,070 cases and 13 deaths were reported by 41 countries. Therefore, the rising incidence of measles and chickenpox is driving the growth of the proquad market.

What Is Driving The Proquad Market? Impact Of Rising Healthcare Expenditures On The Growth Of The Market

Increasing healthcare expenditures are anticipated to fuel the growth of the proquad market. Healthcare expenditures refer to the total amount spent on healthcare-related services, products, and activities within a specified period, typically on an individual, community, national, or global level. Increasing healthcare expenditures are driven by factors such as the rising prevalence of chronic diseases, an aging population, advancements in medical technology, and growing demand for more advanced treatments and healthcare services. Healthcare expenditures support proquad by funding immunization programs, enhancing accessibility, promoting public awareness, and ensuring the infrastructure and insurance coverage needed for its widespread adoption and efficacy. For instance, in May 2023, the Office for National Statistics, a UK-based government department, reported that in 2023, healthcare expenditure in the UK was approximately $362 billion (£292 billion), reflecting a nominal increase of 5.6%. Additionally, long-term health and social care expenditure rose by 2.8% in real terms in 2022. Therefore, increasing healthcare expenditure is driving the growth of the proquad market.

Who Are The Major Players In The Global Proquad Market?

Major companies operating in the proquad market are Merck and Co. Inc.

What Are The Key Trends Of The Global Proquad Market? Role Of Intramuscular Administration In Improving Vaccine Delivery Efficiency

A key trend in the proquad market is the focus on expansion of vaccine administration options such as intramuscular (IM) administration to enhance convenience and consistency in immunization practices. Intramuscular (IM) administration refers to the delivery of a vaccine or medication directly into the muscle tissue, allowing for faster absorption into the bloodstream. For instance, in March 2023, Merck & Co. Inc., a US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for the addition of an intramuscular (IM) administration option to the U.S. Product Insert (USPI) for its MMRV vaccine family, including ProQuad. With this approval, the MMRV family joins other commonly recommended vaccines that can be given intramuscularly. Healthcare professionals in the U.S. now have the option to administer all routinely recommended injectable pediatric vaccines in the CDC immunization schedule via the same IM route. M-M-R II, VARIVAX, and ProQuad are the only measles, mumps, rubella, and varicella vaccines approved for IM administration in the U.S. The MMRV family of vaccines is also licensed for IM use in the European Union.

Regional Analysis For The Global Proquad Market

North America was the largest region in the proquad market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proquad market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the proquad market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Proquad Market?

The proquad market consists of sales of proquad lyophilized suspension for injection, subcutaneous injection and intramuscular injection. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Proquad Industry?

The proquad market research report is one of a series of new reports from The Business Research Company that provides proquad market statistics, including proquad industry global market size, regional shares, competitors with a proquad market share, detailed proquad market segments, market trends and opportunities, and any further data you may need to thrive in the proquad industry. This proquad market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Proquad Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The proquad market covered in this report is segmented – 1) By Indication: Measles; Mumps; Rubella; Varicella 2) By Patient Type: Pediatric Patient; Adult Patient 3) By End User: Healthcare Providers; Pharmacies; Public Health Organization
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck and Co. Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Proquad Market Characteristics

3. Proquad Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Proquad Market Trends And Strategies

5. Proquad Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Proquad Growth Analysis And Strategic Analysis Framework

6.1. Global Proquad PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Proquad Market Growth Rate Analysis

6.4. Global Proquad Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Proquad Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Proquad Total Addressable Market (TAM)

7. Global Proquad Pricing Analysis & Forecasts

8. Proquad Market Segmentation

8.1. Global Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Measles

Mumps

Rubella

Varicella

8.2. Global Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pediatric Patient

Adult Patient

8.3. Global Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Healthcare Providers

Pharmacies

Public Health Organization

9. Global Proquad Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Proquad Market Regional And Country Analysis

10.1. Global Proquad Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Proquad Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Proquad Market

11.1. Asia-Pacific Proquad Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Proquad Market

12.1. China Proquad Market Overview

12.2. China Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Proquad Market

13.1. India Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Proquad Market

14.1. Japan Proquad Market Overview

14.2. Japan Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Proquad Market

15.1. Australia Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Proquad Market

16.1. South Korea Proquad Market Overview

16.2. South Korea Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Proquad Market

17.1. Western Europe Proquad Market Overview

17.2. Western Europe Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Proquad Market

18.1. UK Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Proquad Market

19.1. Germany Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Proquad Market

20.1. France Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Proquad Market

21.1. Eastern Europe Proquad Market Overview

21.2. Eastern Europe Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Proquad Market

22.1. North America Proquad Market Overview

22.2. North America Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Proquad Market

23.1. USA Proquad Market Overview

23.2. USA Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Proquad Market

24.1. Canada Proquad Market Overview

24.2. Canada Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Proquad Market

25.1. South America Proquad Market Overview

25.2. South America Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Proquad Market

26.1. Middle East Proquad Market Overview

26.2. Middle East Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Proquad Market

27.1. Africa Proquad Market Overview

27.2. Africa Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Proquad Market Competitive Landscape And Company Profiles

28.1. Proquad Market Competitive Landscape

28.2. Proquad Market Company Profiles

28.2.1. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Proquad Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Proquad Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Proquad Market

32. Recent Developments In The Proquad Market

33. Proquad Market High Potential Countries, Segments and Strategies

33.1 Proquad Market In 2029 - Countries Offering Most New Opportunities

33.2 Proquad Market In 2029 - Segments Offering Most New Opportunities

33.3 Proquad Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Proquad Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Proquad Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Merck and Co. Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Proquad Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Proquad Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Proquad Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Proquad Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Proquad Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Merck and Co. Inc. Financial Performance

How is the Anti-Aging Market Poised for Growth: Trends and Opportunities Through 2034

What’s Driving Growth in the Anticoagulants Market? Insights into Key Trends and Opportunities

Comprehensive Analysis of the Biomarkers Market 2025-2034: Growth Rates, Trends, and Future Opportunities

How Will the Botanical Supplements Market Grow? Key Trends and Opportunities for 2025 and Beyond

Cancer Immunotherapy Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Comprehensive Analysis of the Compression Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

Unlocking the Future of the Contraceptives Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Contract Development Manufacturing Organizations Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

Drug Delivery Devices Market 2021 - By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Autoimmune Disease Diagnosis Market 2022 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests), And By Region, Opportunities And Strategies – Global Forecast To 2031

View Report

Autoimmune Treatment Global Market Report 2025 – By Product (Consumables and Assay Kits, Instruments, Services), By Service Type (Consultation and Diagnosis, Therapy and monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), By Drug Class (Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class), By End User (Clinical Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immune Health Supplements Global Market Report 2025 – By Ingredients Type( Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form( Soft Gels Or Capsules, Tablets, Powder, Liquid, Other Forms), By Source Type( Plant-Based, Animal-Based), By Distribution Channel( Pharmacies and Drug Stores, Hypermarket or Supermarket, Online Stores, Specialty Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2025 – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Colorectal Cancer, Other Applications), By End-Users (Hospitals, Specialty Clinics, Academic and Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chickenpox Vaccine Global Market Report 2025 – By Vaccine (Monovalent varicella vaccine, Combination varicella vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Chickenpox Vaccination), By End-Users (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2025-2034

View Report

G-CSF (Granulocyte Colony Stimulating Factors) Market 2021 - By Type (Pegfilgrastim, Filgrastim, Lenograstim), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Proquad market?

Proquad is a vaccine designed to protect against measles, mumps, rubella (MMR), and varicella (chickenpox). It is a combination vaccine, meaning it combines multiple vaccines into one shot to reduce the number of injections needed for immunization. It is used primarily in children, typically administered as a single dose for those between 12 months and 12 years of age. For further insights on the Proquad market, request a sample here

How will the Proquad market drivers and restraints affect the market dynamics? What forces will shape the Proquad industry going forward?

The Proquad market major growth driver - Rising Measles And Chickenpox Cases Drive Growth In The Market. For further insights on the Proquad market, request a sample here

What is the forecast market size or the forecast market value of the Proquad market?

The Proquad market size has grown strongly in recent years. The proquad market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to established immunization schedules, combination vaccine advantages, government-supported vaccination programs, epidemic outbreaks, strong healthcare infrastructure, and regulatory approvals. The proquad market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to population growth, improved access to healthcare, global health initiatives, rising awareness of vaccine-preventable diseases, government vaccination funding, and a growing focus on preventive healthcare. Major trends in the forecast period include global vaccination coverage, technological advancements in vaccine delivery, integration of vaccines in routine health systems, improvements in vaccine accessibility, and increased awareness of vaccine safety. For further insights on the Proquad market, request a sample here

How is the Proquad market segmented?

The proquad market covered in this report is segmented –
1) By Indication: Measles; Mumps; Rubella; Varicella
2) By Patient Type: Pediatric Patient; Adult Patient
3) By End User: Healthcare Providers; Pharmacies; Public Health Organization For further insights on the Proquad market, request a sample here

Which region has the largest share of the Proquad market? What are the other regions covered in the report?

Who are the major players in the Proquad market?

Major companies operating in the proquad market are Merck and Co. Inc. . For further insights on the Proquad market, request a sample here.

What are the key trends in the Proquad market?

Major trends in the Proquad market include Role Of Intramuscular Administration In Improving Vaccine Delivery Efficiency. For further insights on the Proquad market, request a sample here.

What are the major opportunities in the Proquad market? What are the strategies for the Proquad market?

For detailed insights on the major opportunities and strategies in the Proquad market, request a sample here.

How does the Proquad market relate to the overall economy and other similar markets?

For detailed insights on Proquad's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Proquad industry?

For detailed insights on the mergers and acquisitions in the Proquad industry, request a sample here.

What are the key dynamics influencing the Proquad market growth? SWOT analysis of the Proquad market.

For detailed insights on the key dynamics influencing the Proquad market growth and SWOT analysis of the Proquad industry, request a sample here.

Proquad Global Market Report 2025

Proquad Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Measles, Mumps, Rubella, Varicella), By Patient Type (Pediatric Patient, Adult Patient), By End User (Healthcare Providers, Pharmacies, Public Health Organization)

Proquad Global Market Report 2025

Market Insights

Related Reports

What Is Covered Under Proquad Market?

What Is The Proquad Market Size 2025 And Growth Rate?

What Is The Proquad Market Growth Forecast?

How Is The Proquad Market Segmented?

What Is Driving The Proquad Market? Rising Measles And Chickenpox Cases Drive Growth In The Market

What Is Driving The Proquad Market? Impact Of Rising Healthcare Expenditures On The Growth Of The Market

Who Are The Major Players In The Global Proquad Market?

What Are The Key Trends Of The Global Proquad Market? Role Of Intramuscular Administration In Improving Vaccine Delivery Efficiency

Regional Analysis For The Global Proquad Market

What Defines the Proquad Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Proquad Industry?

Table Of Contents

List Of Tables

List Of Figures

How is the Anti-Aging Market Poised for Growth: Trends and Opportunities Through 2034

What’s Driving Growth in the Anticoagulants Market? Insights into Key Trends and Opportunities

Comprehensive Analysis of the Biomarkers Market 2025-2034: Growth Rates, Trends, and Future Opportunities

How Will the Botanical Supplements Market Grow? Key Trends and Opportunities for 2025 and Beyond

Cancer Immunotherapy Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Comprehensive Analysis of the Compression Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

Unlocking the Future of the Contraceptives Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Contract Development Manufacturing Organizations Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

G-CSF (Granulocyte Colony Stimulating Factors) Market 2021 - By Type (Pegfilgrastim, Filgrastim, Lenograstim), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

Frequently Asked Questions